Table 1

Demographic and behavioural characteristics of 319 PEP presentations to RPA Sexual Health

n (%)
Age
 <30134 (42.0)
 30–39111 (34.8)
 ≥4074 (23.2)
Gender*
 Male302 (95.0)
 Female16 (5.0)
Year of PEP prescription
 200886 (27.0)
 200973 (22.9)
 201083 (26.0)
 201177 (24.1)
Highest risk exposure leading to PEP†
 Receptive penile-anal†203 (63.6)
 Insertive penile-anal†87 (27.4)
 Receptive penile-vaginal‡12 (3.8)
 Insertive penile-vaginal0 (0)
 Receptive penile-oral§5 (1.6)
 Needle-sharing¶4 (1.3)
 Needlestick injury¶5 (1.6)
 Other**3 (0.9)
Clinic of original PEP prescription
 RPA Sexual Health147 (46.1)
 Other172 (53.9)
Number of male sexual partners in past year
 <576 (27.2)
 5–1070 (21.9)
 11–2051 (16.0)
 21–5055 (17.2)
 >5027 (8.5)
 Missing40 (12.5)
Condom use for anal and/or vaginal sex with casual partners in past year
 No casual partner(s)21 (6.6)
 0%8 (2.5)
 >0% but <50%20 (6.3)
 ≥50% but <100%125 (39.2)
 100%131 (41.1)
 Missing14 (4.4)
Condom use for anal and/or vaginal sex with regular partners in past year
 No regular partner(s)114 (35.7)
 0%34 (10.7)
 >0% but <50%20 (6.3)
 ≥50% but <100%58 (18.2)
 100%80 (25.1)
 Missing13 (4.1)
  • *Excludes one transgender participant.

  • †All anal exposures were between males.

  • ‡3/12 known HIV-positive source; 2/12 bisexual male source of unknown HIV serostatus; 5/12 sexual assault by unknown male.

  • §4/5 sources HIV-positive.

  • ¶All sources HIV-positive.

  • **All potential high-risk blood-to-blood contact due to trauma/injury.

  • PEP, post-exposure prophylaxis.